Publication

Deep Brain Stimulation for Dystonia: A Novel Perspective on the Value of Genetic Testing

Downloadable Content

Persistent URL
Last modified
  • 03/14/2025
Type of Material
Authors
    Hyder A Jinnah, Emory UniversityRon Alterman, Beth Israel Deaconess Medical CenterChristine Klein, University of LubeckJoachim K. Krauss, Hannover Medical SchoolElena Moro, Centre Hospitalier Universitaire de GrenobleMarie Vidailhet, Hôpital de la SalpêtrièreRobert Raike, Medtronic Inc.
Language
  • English
Date
  • 2017-04-01
Publisher
  • Springer Verlag (Germany)
Publication Version
Copyright Statement
  • © Springer-Verlag Wien 2017
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0300-9564
Volume
  • 124
Issue
  • 4
Start Page
  • 417
End Page
  • 430
Grant/Funding Information
  • This article was supported in part by Medtronic.
  • CK is supported by DYSTRACT (BMBF) and is the recipient of a career development award from the Hermann and Lilly Schilling Foundation.
  • HAJ also is supported by grants to the Dystonia Coalition from the National Center for Advancing Translational Studies (U54 TR001456) and the National Institute of Neurological Disorders and Stroke (U54 NS065701) at the NIH.
Abstract
  • The dystonias are a group of disorders characterized by excessive muscle contractions leading to abnormal movements and postures. There are many different clinical manifestations and underlying causes. Deep brain stimulation (DBS) provides an effect treatment, but outcomes can vary considerably among the different subtypes of dystonia. Several variables are thought to contribute to this variation including age of onset and duration of dystonia, specific characteristics of the dystonic movements, location of stimulation and stimulator settings, and others. The potential contributions of genetic factors have received little attention. In this review, we summarize evidence that some of the variation in DBS outcomes for dystonia is due to genetic factors. The evidence suggests that more methodical genetic testing may provide useful information in the assessment of potential surgical candidates, and in advancing our understanding of the biological mechanisms that influence DBS outcomes.
Author Notes
  • H. A. Jinnah, M.D., Ph.D., Professor, Departments of Neurology, Human Genetics & Pediatrics, Emory University, Suite 6300 Woodruff Memorial Building, 101 Woodruff Circle, Atlanta GA, 30322, Phone: 404-727-9107, Fax: 404-712-8576, hjinnah@emory.edu
Keywords
Research Categories
  • Biology, Genetics
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items